Peking University People's Hospital
Peking University People's Hospital
Beijing, Beijing Municipality, China146 results · Page 1 of 6
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VAAPS Combined With Loose Seton Drainage for Postoperative Self-Care: A Prospective Single-Arm Cohort Study | Cysts, neoplasm, pilonidal sinus | Recruiting | Not applicable | 2026-10-07 | NCT07855107 | |
| LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, microinvasive gastric cancer, neoplasm, stomach disorder | Recruiting | Not stated | 2026-10-05 | NCT07857668 | |
| ADC Based Therapy Accroding to HER2 Heterogeneous | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2026-10-02 | NCT07844018 | |
| A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors（G-MAP 101） | Advanced Solid Tumors With MTAP Deletion | Recruiting | Phase 1 | 2026-10-02 | NCT06796699 | |
| Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07835152 | |
| A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07792954 | |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-09-25 | NCT06679140 | |
| A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Recruiting | Phase 3 | 2026-09-23 | NCT07416526 | |
| A Study of VCT220 in Participants With Hypertension and Obesity or Overweight | cardiovascular disorder, hypertensive disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-09-21 | NCT07360275 | |
| A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 3 | 2026-09-18 | NCT06873945 | |
| Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-16 | NCT07792681 | |
| Baricitinib for Post-HSCT Persistent Thrombocytopenia | Allogeneic Hematopoietic Stem Cell Transplantation; Persistent Thrombocytopenia | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT07535645 | |
| Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis | Prurigo Nodularis (PN) | Recruiting | Phase 2 | 2026-09-14 | NCT07236099 | |
| Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-09-14 | NCT06514508 | |
| a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND） | cancer, neoplasm | Recruiting | Not stated | 2026-09-11 | NCT06217900 | |
| A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT06049290 | |
| A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07812597 | |
| Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 2 | 2026-09-01 | NCT07796516 | |
| Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations | Neoplasms by Site, Thoracic Neoplasms, bronchial disorder, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-09-01 | NCT07185997 | |
| Clinical Validation of a Pre-trained and Fine-tuned Model for Analyzing Time-Series Electronic Health Records in Critical Care | Critical Care Medicine; Mortality Prediction | Recruiting | Not stated | 2026-08-31 | NCT07795450 | |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT06932003 | |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT06931990 | |
| Mass Spectrometry-based Immune Profiling in Autoimmune Diseases | Arthritis, Gouty, Axial Spondyloarthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, cardiovascular disorder, connective tissue disorder, gout, hereditary disease, immune system disorder, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, osteoarthritis, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatoid arthritis, skin disorder, spondylitis, systemic sclerosis, vascular disorder, vasculitis, vertebral column disorder | Enrolling by invitation | Not stated | 2026-08-26 | NCT07188285 | |
| A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia | Nutritional and Metabolic Diseases, hyperphosphatemia, metabolic disease, phosphorus metabolism disease | Recruiting | Phase 2 | 2026-08-26 | NCT06712654 | |
| Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer | Adnexal Diseases, Carcinoma, Endometrioid, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, follicular lymphoma, gonadal disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, ovarian cancer, ovarian disorder, uterine disorder | Recruiting | Not applicable | 2026-08-21 | NCT06468215 |